Karina Daily Moisturizer SPF 25
CGMP Deviations
Yes — there is an active recall. 6 ongoing FDA recalls mention Octinoxate (24 total). Check the affected lots below.
Most common reason: cGMP deviation (12 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Octinoxate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations
CGMP Deviations
CGMP Deviations
GMP Deviations
Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.
Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.
Superpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.
Superpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.
Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.
CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.
Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.
GMP Deviations
GMP Deviations
Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
Failed Stability Specifications:stability failure at 12 months, long term RT conditions.
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.
Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.
cGMP Deviations; product does not comply with cGMP requirements
cGMP Deviations; product does not comply with cGMP requirements
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.